US2372661015 - Common Stock

Overall **DAR** gets a fundamental rating of **5** out of 10. We evaluated **DAR** against 92 industry peers in the **Food Products** industry. While **DAR** belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. **DAR** has a correct valuation and a medium growth rate.

In the past year **DAR** was profitable.

Measured over the past 3 years, the **Average Return On Invested Capital** for **DAR** is in line with the industry average of **7.56%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.86% | ||

ROE | 14.06% | ||

ROIC | 5.23% |

ROA(3y)8.16%

ROA(5y)7.12%

ROE(3y)17.76%

ROE(5y)15.14%

ROIC(3y)7.15%

ROIC(5y)5.19%

In the last couple of years the **Operating Margin** of **DAR** has grown nicely.

The **Gross Margin** of **DAR** (**24.23%**) is better than **61.54%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 8.85% | ||

PM (TTM) | 9.54% | ||

GM | 24.23% |

OM growth 3Y25.8%

OM growth 5Y21.47%

PM growth 3Y4.72%

PM growth 5Y26.07%

GM growth 3Y-0.64%

GM growth 5Y2.08%

The number of shares outstanding for **DAR** has been reduced compared to 1 year ago.

The number of shares outstanding for **DAR** has been reduced compared to 5 years ago.

The debt/assets ratio for **DAR** is higher compared to a year ago.

An Altman-Z score of **1.99** indicates that **DAR** is not a great score, but indicates only limited risk for bankruptcy at the moment.

The Debt to FCF ratio of **DAR** is **12.88**, which is on the high side as it means it would take **DAR**, **12.88** years of fcf income to pay off all of its debts.

A Debt/Equity ratio of **0.95** indicates that **DAR** is somewhat dependend on debt financing.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.95 | ||

Debt/FCF | 12.88 | ||

Altman-Z | 1.99 |

ROIC/WACC0.65

WACC8.03%

A Current Ratio of **1.86** indicates that **DAR** should not have too much problems paying its short term obligations.

Looking at the **Quick ratio**, with a value of **1.10**, **DAR** is in the better half of the industry, outperforming **67.03%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.86 | ||

Quick Ratio | 1.1 |

The earnings per share for **DAR** have decreased strongly by **-12.44%** in the last year.

The **Earnings Per Share** has been growing by **50.52%** on average over the past years. This is a very strong growth

Looking at the last year, **DAR** shows a small growth in **Revenue**. The Revenue has grown by **3.92%** in the last year.

The **Revenue** has been growing by **14.91%** on average over the past years. This is quite good.

EPS 1Y (TTM)-12.44%

EPS 3Y26.21%

EPS 5Y50.52%

EPS growth Q2Q-45.83%

Revenue 1Y (TTM)3.92%

Revenue growth 3Y23.87%

Revenue growth 5Y14.91%

Revenue growth Q2Q-8.71%

The **Earnings Per Share** is expected to grow by **13.97%** on average over the next years. This is quite good.

Based on estimates for the next years, **DAR** will show a decrease in **Revenue**. The Revenue will decrease by **-0.39%** on average per year.

EPS Next Y-11.55%

EPS Next 2Y6.58%

EPS Next 3Y6.56%

EPS Next 5Y13.97%

Revenue Next Year-9.16%

Revenue Next 2Y-1.83%

Revenue Next 3Y-0.39%

Revenue Next 5YN/A

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

A **Price/Earnings** ratio of **10.88** indicates a reasonable valuation of **DAR**.

When comparing the **Price/Earnings** ratio of **DAR** to the average of the S&P500 Index (**24.95**), we can say **DAR** is valued rather cheaply.

A **Price/Forward Earnings** ratio of **12.30** indicates a correct valuation of **DAR**.

85.71% of the companies in the same industry are more expensive than **DAR**, based on the **Price/Forward Earnings** ratio.

Compared to an average S&P500 **Price/Forward Earnings** ratio of **21.40**, **DAR** is valued a bit cheaper.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 10.88 | ||

Fwd PE | 12.3 |

67.03% of the companies in the same industry are more expensive than **DAR**, based on the **Price/Free Cash Flow** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 19.93 | ||

EV/EBITDA | 10.08 |

PEG (NY)N/A

PEG (5Y)0.22

EPS Next 2Y6.58%

EPS Next 3Y6.56%

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**DARLING INGREDIENTS INC**

NYSE:DAR (4/22/2024, 4:58:40 PM)

After market: 42.88 0 (0%)**42.88**

**+0.27 (+0.63%) **

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap6.85B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 10.88 | ||

Fwd PE | 12.3 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)0.22

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.86% | ||

ROE | 14.06% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 8.85% | ||

PM (TTM) | 9.54% | ||

GM | 24.23% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.61

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.95 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.86 | ||

Quick Ratio | 1.1 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-12.44%

EPS 3Y26.21%

EPS 5Y

EPS growth Q2Q

EPS Next Y-11.55%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)3.92%

Revenue growth 3Y23.87%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y